April 2009
Volume 50, Issue 13
ARVO Annual Meeting Abstract  |   April 2009
Sterile Endophthalmitis Secondary to Intravitreal Triesence (Triamcinolone Acetonide)
Author Affiliations & Notes
  • J. L. Krah
    Illinois Retina Center, Springfield, Illinois
  • D. Krimmel
    Illinois Retina Center, Springfield, Illinois
  • D. Dodwell
    Illinois Retina Center, Springfield, Illinois
  • Footnotes
    Commercial Relationships  J.L. Krah, None; D. Krimmel, None; D. Dodwell, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 3565. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J. L. Krah, D. Krimmel, D. Dodwell; Sterile Endophthalmitis Secondary to Intravitreal Triesence (Triamcinolone Acetonide). Invest. Ophthalmol. Vis. Sci. 2009;50(13):3565.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : To report the incidence and clinical course of sterile endophthalmitis associated with office-based intravitreal injection of Triesence (triamcinolone acetonide).

Methods: : This is a retrospective, consecutive, single center case series. All patients received at least one injection of Triesence. Patients were treated with 4-8 mg/ 0.1-0.2ml of intravitreal "preservative free" Triesence. The procedure was performed with sterile gloves, 10% Povidone Iodine prep, a sterile lid speculum and antibiotic drops. Follow-up after each injection was at least 2 months.

Results: : A total of 38 injections of intravitreal Triesence were given during the study period. Sterile endophthalmitis developed in 2 patients (5.3%). Both patients experienced a dramatic, painless decrease in pre-treatment Snellen visual acuity (VA) from 20/60 and 20/100 to the Hand Motion level within 24 hours of their injection. A sterile hypopyon with dense vitreous inflammation was observed in both patients. The VA improved to baseline at 2 months after injection in both patients.

Keywords: endophthalmitis • corticosteroids • drug toxicity/drug effects 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.